Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

The study is the latest showing apixaban may be the safest of the DOACs when it comes to bleeding, say experts.

Related Keywords

Phoenix ,Arizona ,United States ,Iceland ,Canada ,Philadelphia ,Pennsylvania ,American ,Canadian ,Ghadeerk Dawwas ,Neena Abraham ,Daiichi Sankyo ,Bayer Janssen ,Bristol Myers Squibb ,American Heart Association ,Heart Rhythm Society ,University Of Pennsylvania Perelman School Medicine ,American College Of Cardiology ,Boehringer Ingelheim ,Internal Medicine ,Pennsylvania Perelman School ,Mayo Clinic ,American College ,Not Ready ,Guideline Changes ,